NO974615L - Emulsjon som egner seg for administrering av lite vannopplöselige, fotosensitiserende forbindelser, samt anvendelse derav - Google Patents

Emulsjon som egner seg for administrering av lite vannopplöselige, fotosensitiserende forbindelser, samt anvendelse derav

Info

Publication number
NO974615L
NO974615L NO974615A NO974615A NO974615L NO 974615 L NO974615 L NO 974615L NO 974615 A NO974615 A NO 974615A NO 974615 A NO974615 A NO 974615A NO 974615 L NO974615 L NO 974615L
Authority
NO
Norway
Prior art keywords
administration
low water
emulsion suitable
photosensitizing compounds
soluble
Prior art date
Application number
NO974615A
Other languages
English (en)
Other versions
NO974615D0 (no
NO321260B1 (no
Inventor
Robert T Lyons
Original Assignee
Pharmacia & Upjohn Ab
Miravant Medical Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab, Miravant Medical Technologies filed Critical Pharmacia & Upjohn Ab
Publication of NO974615D0 publication Critical patent/NO974615D0/no
Publication of NO974615L publication Critical patent/NO974615L/no
Publication of NO321260B1 publication Critical patent/NO321260B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Colloid Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19974615A 1995-04-11 1997-10-06 Emulsjon som egner seg for administrering av lite vannopploselige, fotosensitiserende forbindelser, samt anvendelse derav NO321260B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/419,911 US5616342A (en) 1995-04-11 1995-04-11 Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
PCT/US1996/004971 WO1996032094A1 (en) 1995-04-11 1996-04-10 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof

Publications (3)

Publication Number Publication Date
NO974615D0 NO974615D0 (no) 1997-10-06
NO974615L true NO974615L (no) 1997-10-06
NO321260B1 NO321260B1 (no) 2006-04-10

Family

ID=23664263

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974615A NO321260B1 (no) 1995-04-11 1997-10-06 Emulsjon som egner seg for administrering av lite vannopploselige, fotosensitiserende forbindelser, samt anvendelse derav

Country Status (16)

Country Link
US (1) US5616342A (no)
EP (1) EP0825851B1 (no)
JP (1) JPH11502520A (no)
AR (1) AR001602A1 (no)
AT (1) ATE270543T1 (no)
AU (1) AU706848B2 (no)
CA (1) CA2217573C (no)
DE (1) DE69632858T2 (no)
ES (1) ES2225880T3 (no)
IL (1) IL117990A (no)
MY (1) MY116509A (no)
NO (1) NO321260B1 (no)
PT (1) PT825851E (no)
TW (1) TW505526B (no)
WO (1) WO1996032094A1 (no)
ZA (1) ZA962854B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6375930B2 (en) 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6316215B1 (en) 1999-12-27 2001-11-13 Edwin L. Adair Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7229447B1 (en) 1998-08-25 2007-06-12 Advanced Photodynamics Technologies, Inc. Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
IT1303603B1 (it) 1998-12-16 2000-11-14 Giovanni Sacco Procedimento a tassonomia dinamica per il reperimento di informazionisu grandi banche dati eterogenee.
US6956048B2 (en) * 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US7389351B2 (en) * 2001-03-15 2008-06-17 Microsoft Corporation System and method for identifying and establishing preferred modalities or channels for communications based on participants' preferences and contexts
US6608050B2 (en) 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6190877B1 (en) 1999-12-27 2001-02-20 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques
US6984498B2 (en) * 1999-12-27 2006-01-10 Adair Edwin L Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US6750037B2 (en) 1999-12-27 2004-06-15 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
WO2001062289A2 (en) 2000-02-26 2001-08-30 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
CA2408332C (en) * 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
CA2408323C (en) * 2000-05-08 2012-06-12 The University Of British Columbia Drug delivery systems for photodynamic therapy
US6605606B1 (en) * 2000-08-04 2003-08-12 Miravant Pharmaceuticals, Inc. Solid forms of tin ethyl etiopurpurin and processes for producing such forms
US6627288B1 (en) 2000-08-10 2003-09-30 Mitsui Chemicals, Inc. Optical recording medium and porphycene compound
US20030212052A1 (en) * 2001-04-20 2003-11-13 David Kessel Use of ursdeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
EP1453425B1 (en) 2001-12-03 2006-03-08 Ekos Corporation Catheter with multiple ultrasound radiating members
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
ATE336266T1 (de) * 2002-06-21 2006-09-15 Adair Edwin Lloyd Anwendung von metalloporphyrinen zur behandlung von arteriosklerose
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
US20050186230A1 (en) * 2004-01-23 2005-08-25 Sd Pharmaceuticals, Inc. Elemene compositions containing liquid oil
US8709449B2 (en) * 2004-02-12 2014-04-29 Biolitec Pharma Marketing Ltd Methods and compositions for improving photodynamic therapy through administration of lipids
ES2660172T3 (es) * 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
JP4462051B2 (ja) * 2005-01-28 2010-05-12 富士ゼロックス株式会社 微粒子分散液の濃縮方法、及び微粒子分散液の濃縮装置
WO2007035311A2 (en) * 2005-09-16 2007-03-29 University Of Massachusetts Lowell Anti-oxidant synergy formulation nanoemulsions to treat cancer
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
EP2494932B1 (en) 2007-06-22 2020-05-20 Ekos Corporation Apparatus for treatment of intracranial hemorrhages
US20090187137A1 (en) * 2007-12-14 2009-07-23 Kim Volz Ultrasound pulse shaping
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter
US10723694B2 (en) * 2018-10-02 2020-07-28 Kuwait University Propargyl-functionalized macrocyclic compounds
WO2020236802A1 (en) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprising biologically active agents and bile salts

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
US4877872A (en) * 1986-06-24 1989-10-31 The University Of Toledo Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
US5109129A (en) * 1989-09-29 1992-04-28 The University Of Toledo, Medical College Of Ohio Porphyrin derivatives
US5250668A (en) * 1988-01-11 1993-10-05 Morgan Alan R Production and use of porphyrin derivatives and of compositions containing such derivatives
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
CA1337397C (en) * 1988-09-29 1995-10-24 Hideo Nakajima Emulsified composition
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
DE69115990T2 (de) * 1990-05-29 1996-05-30 Ocular Res Of Bonton Inc Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
CA2052950A1 (en) * 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis

Also Published As

Publication number Publication date
ES2225880T3 (es) 2005-03-16
MY116509A (en) 2004-02-28
EP0825851B1 (en) 2004-07-07
EP0825851A4 (en) 2000-08-09
AR001602A1 (es) 1997-11-26
NO974615D0 (no) 1997-10-06
DE69632858D1 (de) 2004-08-12
JPH11502520A (ja) 1999-03-02
PT825851E (pt) 2004-11-30
WO1996032094A1 (en) 1996-10-17
AU5540196A (en) 1996-10-30
US5616342A (en) 1997-04-01
CA2217573C (en) 2001-11-27
AU706848B2 (en) 1999-06-24
IL117990A (en) 2001-01-28
CA2217573A1 (en) 1996-10-17
ZA962854B (en) 1996-10-11
DE69632858T2 (de) 2005-09-01
EP0825851A1 (en) 1998-03-04
ATE270543T1 (de) 2004-07-15
NO321260B1 (no) 2006-04-10
IL117990A0 (en) 1996-08-04
TW505526B (en) 2002-10-11

Similar Documents

Publication Publication Date Title
NO974615L (no) Emulsjon som egner seg for administrering av lite vannopplöselige, fotosensitiserende forbindelser, samt anvendelse derav
NO308303B1 (no) Vannløselige rapamycinestere, anvendelse derav samt farmasøytisk blanding som omfatter forbindelsene
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
FI964028L (fi) Uusi farmaseuttinen formulaatio ja menetelmä
FI945900A7 (fi) Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi
FI964249A0 (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
AU5740496A (en) Micromechanical device and method for enhancing delivery of compounds through the skin
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
DE69613647D1 (de) Wasser-in-Öl-Emulsion enthaltendes kosmetisches Präparat
FI961525L (fi) Uusi emulsioformulaatio
AU4642796A (en) High pressure washout of explosive agents
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU698057B2 (en) Thickened and stabilized cosmetic emulsion compositions
DK0853617T3 (da) 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivater
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
FI945975L (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
AU5274898A (en) Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
DE59610836D1 (de) Mittel gegen parasitäre protozoen
AU7691996A (en) Aqueous polymer emulsion
AU7400196A (en) Fluid administration apparatus
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI973229L (fi) Uusi farmaseuttinen koostumus
ID16081A (id) Penggunaan turunan trisiklik dari 1,4-dihidro-1,4-diokso-1h-naftalena senyawa-senyawa yang diperolehnya dan penerapannya dalam terapi